1 Stern-Ginossar N, "Receptors on NK cells, In Natural killer cells: basic science and clinical application. 1st ed" Academic Press 155-168, 2010
2 Terme M, "Natural killer cell-directed therapies: moving from unexpected results to successful strategies" 9 : 486-494, 2008
3 Cho D, "Cytotoxicity of activated natural killer cells against pediatric solid tumors" 16 : 3901-3909, 2010
4 Cooley S, "Clinical trials of NK cells for cancer, In Natural killer cells: basic science and clinical application. 1st ed" Academic Press 555-570, 2010
5 Bekaii-Saab TS, "A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies" 8 : 2983-2991, 2009
1 Stern-Ginossar N, "Receptors on NK cells, In Natural killer cells: basic science and clinical application. 1st ed" Academic Press 155-168, 2010
2 Terme M, "Natural killer cell-directed therapies: moving from unexpected results to successful strategies" 9 : 486-494, 2008
3 Cho D, "Cytotoxicity of activated natural killer cells against pediatric solid tumors" 16 : 3901-3909, 2010
4 Cooley S, "Clinical trials of NK cells for cancer, In Natural killer cells: basic science and clinical application. 1st ed" Academic Press 555-570, 2010
5 Bekaii-Saab TS, "A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies" 8 : 2983-2991, 2009